Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |